Retatrutide Drug Interactions: Complete Reference

Retatrutide is a triple agonist (GLP-1/GIP/glucagon) that interacts with the body through unique mechanisms, and understanding how it interfaces with other medications is essential for safe use. While retatrutide has few direct pharmacokinetic drug-drug interactions, its effects on gastric emptying, blood sugar, blood pressure, body weight, and appetite create indirect interactions that require attention. This comprehensive reference covers every major medication class (Jastreboff et al., NEJM 2023).

Medical Disclaimer: This article is for informational purposes only. Retatrutide is an investigational drug not yet approved by the FDA. Always disclose all medications to your healthcare provider before starting any new treatment. Never adjust medications without medical guidance.

Key Interaction Mechanisms

Before reviewing specific medications, understanding the three main ways retatrutide can affect other drugs helps put individual interactions in context:

Delayed gastric emptying: Retatrutide's GLP-1 activity slows stomach emptying, potentially delaying or reducing absorption of oral medications. This is the most clinically relevant class effect.
Metabolic improvement: Dramatic weight loss and improved insulin sensitivity can change the dose requirements of diabetes, blood pressure, and cholesterol medications.
GI side effects: Nausea, vomiting, and diarrhea can affect oral medication absorption and cause dehydration that alters drug concentrations.

Complete Drug Interaction Reference

Diabetes Medications

Medication	Interaction Level	Key Concern	Action
Metformin	Low	Additive GI effects	Safe; use XR formulation
Insulin (all types)	High	Hypoglycemia risk	Reduce insulin proactively; monitor BG closely
Sulfonylureas (glipizide, glimepiride)	High	Hypoglycemia risk	Reduce dose or discontinue; monitor BG
SGLT2 inhibitors (Jardiance, Farxiga)	Moderate	Additive dehydration risk	Ensure hydration; monitor kidney function
DPP-4 inhibitors (Januvia)	Low	Redundant GLP-1 pathway	Usually discontinued; no safety concern
Other GLP-1 RAs (semaglutide, tirzepatide)	Contraindicated	Overlapping mechanism	Do not combine; switch, do not stack
TZDs (pioglitazone)	Low-Moderate	Fluid retention	Monitor for edema; dose may need adjustment

Cardiovascular Medications

Medication	Interaction Level	Key Concern	Action
ACE inhibitors / ARBs	Low	Hypotension with weight loss	Monitor BP; reduce dose as weight drops
Beta-blockers	Low	Opposing heart rate effects	Monitor BP and HR; adjust as needed
Calcium channel blockers	Low	Hypotension with weight loss	Monitor BP; reduce dose as weight drops
Diuretics	Moderate	Dehydration, electrolyte imbalance	Monitor electrolytes; ensure hydration
Statins	Low	None significant	Continue; reassess lipids after weight loss
Warfarin	Moderate-High	INR changes from diet/weight shifts	Frequent INR monitoring
DOACs (Eliquis, Xarelto)	Low-Moderate	Absorption; weight-based dosing	Monitor if weight drops below 60 kg

Thyroid Medications

Medication	Interaction Level	Key Concern	Action
Levothyroxine (Synthroid)	Moderate	Delayed absorption; weight-based dosing	Take on empty stomach; extend wait to 60 min; check TSH q6-8wk
Methimazole / PTU	Low	Minimal	Continue; monitor thyroid levels

Mental Health Medications

Medication	Interaction Level	Key Concern	Action
SSRIs (sertraline, fluoxetine, etc.)	Low	Some cause weight gain	Continue; consider weight-neutral options
SNRIs (venlafaxine, duloxetine)	Low	Minimal	Continue as prescribed
Bupropion (Wellbutrin)	Low	Synergistic weight loss	Safe combination; potentially beneficial
Mirtazapine (Remeron)	Low	Significant weight gain	Discuss alternatives with psychiatrist
Antipsychotics (olanzapine, quetiapine)	Moderate	Weight gain; metabolic effects	Monitor metabolic parameters; may offset weight loss
Lithium	Moderate	Narrow therapeutic window; dehydration risk	Monitor lithium levels; ensure hydration

Hormones and Contraceptives

Medication	Interaction Level	Key Concern	Action
Oral contraceptives	Moderate-High	Reduced absorption	Use backup method or switch to non-oral
Non-oral contraceptives (IUD, implant, patch)	None	Not affected	Continue as normal
Testosterone	Low	Weight loss may improve natural levels	Monitor levels; may need dose adjustment
HRT (estrogen/progesterone)	Low	Oral forms may have delayed absorption	Consider transdermal if on oral HRT

Pain Medications

Medication	Interaction Level	Key Concern	Action
Acetaminophen (Tylenol)	Low	Delayed onset	Safe; preferred pain reliever
NSAIDs (ibuprofen, naproxen)	Moderate	Additive GI irritation; kidney risk	Limit use; take with food; stay hydrated
Opioids	Moderate	Additive GI slowing; constipation	Monitor for severe constipation; delayed absorption
Gabapentin / Pregabalin	Low	Weight gain potential	May partially offset weight loss; continue if needed

Other Common Medications

Medication	Interaction Level	Key Concern	Action
PPIs (omeprazole, pantoprazole)	Low	May help GI symptoms	Safe; may be beneficial
Antibiotics	Low	Delayed absorption timing	Continue as prescribed; monitor for vomiting
Oral steroids (prednisone)	Moderate	Raises blood sugar; causes weight gain	Monitor BG closely; may offset retatrutide benefits
Supplements (vitamins, minerals)	Low	Delayed absorption	Take consistently; monitor B12, vitamin D

General Principles for All Oral Medications

Delayed absorption: All oral medications may be absorbed more slowly due to delayed gastric emptying. For most medications, this changes timing but not total absorption.
Narrow therapeutic index drugs (warfarin, lithium, digoxin, phenytoin, cyclosporine) require enhanced monitoring when starting retatrutide.
Vomiting: If you vomit within 1-2 hours of taking an oral medication, it may not have been absorbed. Contact your provider for guidance.
Weight-based medications: Any drug dosed by weight may need adjustment as body weight changes significantly.
Dehydration-sensitive drugs: Ensure adequate hydration with medications that affect kidney function or are renally excreted.

GLP-1 Treatment With Medication Coordination

Trimi offers compounded semaglutide ($99/month) and compounded tirzepatide ($125/month) with comprehensive medical oversight that includes reviewing your complete medication list for interactions. Learn how Trimi works.

Frequently Asked Questions

Does retatrutide interact with most medications?

Retatrutide has few direct drug-drug interactions. The primary concerns are indirect: delayed absorption of oral medications, additive hypoglycemia risk with diabetes drugs, and dose requirement changes as weight drops. Most medications can be safely continued.

What medications should I never take with retatrutide?

The main contraindication is other GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide). Do not stack GLP-1 medications. All other drug classes can generally be combined with appropriate monitoring.

Should I take my medications at a different time?

For most medications, no timing changes are needed. Exceptions include levothyroxine (extend empty-stomach wait to 60 minutes) and oral contraceptives (consider non-oral alternatives). Take all medications consistently regardless of retatrutide injection day.

How do I know if a medication interaction is causing problems?

Watch for unexpected changes in blood sugar, blood pressure, heart rate, mood, pain control, or bleeding. Report any new symptoms to your provider, especially during the first few months of retatrutide treatment or after dose escalations.